PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Research Development Unit, Hospital Research Development Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran.\', \'Anatomical and Clinical Pathologist, Department of Pathology, Neyshabur University of Medical Sciences, Neyshabur, Iran.\', \'Department of Radiation Oncology, Sabzevar University of Medical Sciences, Sabzevar, Iran.\', \'Department of Internal Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran.\', \'Cancer Research Center, Babol University of Medical Sciences, Babol, Iran.\', \'Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.\', \'Neyshabur University of Medical Sciences, Neyshabur, Iran.\', \'Fred Hutchinson Cancer Research Center, The University of Washington, Seattle, WA, USA.\', \'Department of Radiation Oncology, Edward Hines Jr VA Hospital and Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA.\', \'Student Research Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran.\', \'Radiation Oncologist, Neyshabur University of Medical Sciences, Neyshabur, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/07357907.2021.1995742
?:hasPublicationType
?:journal
  • Cancer investigation
is ?:pmid of
?:pmid
?:pmid
  • 34699294
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.858
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all